238 related articles for article (PubMed ID: 9472613)
1. Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection.
Tamura S; Iwasaki T; Thompson AH; Asanuma H; Chen Z; Suzuki Y; Aizawa C; Kurata T
J Gen Virol; 1998 Feb; 79 ( Pt 2)():291-9. PubMed ID: 9472613
[TBL] [Abstract][Full Text] [Related]
2. Comparison of murine nasal-associated lymphoid tissue and Peyer's patches.
Heritage PL; Underdown BJ; Arsenault AL; Snider DP; McDermott MR
Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1256-62. PubMed ID: 9351630
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of mouse antibody and lymphocyte responses during intranasal vaccination with a lipooligosaccharide-based conjugate vaccine.
Hirano T; Jiao X; Chen Z; Van Waes C; Gu XX
Immunol Lett; 2006 Nov; 107(2):131-9. PubMed ID: 17030407
[TBL] [Abstract][Full Text] [Related]
4. Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses.
Zuercher AW; Coffin SE; Thurnheer MC; Fundova P; Cebra JJ
J Immunol; 2002 Feb; 168(4):1796-803. PubMed ID: 11823512
[TBL] [Abstract][Full Text] [Related]
5. Antigen-specific CD8(+) T cells persist in the upper respiratory tract following influenza virus infection.
Wiley JA; Hogan RJ; Woodland DL; Harmsen AG
J Immunol; 2001 Sep; 167(6):3293-9. PubMed ID: 11544317
[TBL] [Abstract][Full Text] [Related]
6. Upper respiratory tract resistance to influenza infection is not prevented by the absence of either nasal-associated lymphoid tissue or cervical lymph nodes.
Wiley JA; Tighe MP; Harmsen AG
J Immunol; 2005 Sep; 175(5):3186-96. PubMed ID: 16116209
[TBL] [Abstract][Full Text] [Related]
7. Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine.
Asanuma H; Hirokawa K; Uchiyama M; Suzuki Y; Aizawa C; Kurata T; Sata T; Tamura S
Vaccine; 2001 Jul; 19(28-29):3981-9. PubMed ID: 11427274
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of mouse nasal-associated lymphoid tissue.
Asanuma H; Thompson AH; Iwasaki T; Sato Y; Inaba Y; Aizawa C; Kurata T; Tamura S
J Immunol Methods; 1997 Mar; 202(2):123-31. PubMed ID: 9107301
[TBL] [Abstract][Full Text] [Related]
9. Antibody response to influenza infection of mice: different patterns for glycoprotein and nucleocapsid antigens.
Sealy R; Surman S; Hurwitz JL; Coleclough C
Immunology; 2003 Apr; 108(4):431-9. PubMed ID: 12667204
[TBL] [Abstract][Full Text] [Related]
10. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.
Tamura S; Funato H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
Eur J Immunol; 1991 Jun; 21(6):1337-44. PubMed ID: 1646112
[TBL] [Abstract][Full Text] [Related]
11. Phenotypes and functions of persistent Sendai virus-induced antibody forming cells and CD8+ T cells in diffuse nasal-associated lymphoid tissue typify lymphocyte responses of the gut.
Rudraraju R; Surman S; Jones B; Sealy R; Woodland DL; Hurwitz JL
Virology; 2011 Feb; 410(2):429-436. PubMed ID: 21227475
[TBL] [Abstract][Full Text] [Related]
12. IgA antibody-forming cell responses in the nasal-associated lymphoid tissue of mice vaccinated by intranasal, intravenous and/or subcutaneous administration.
Asanuma H; Aizawa C; Kurata T; Tamura S
Vaccine; 1998 Aug; 16(13):1257-62. PubMed ID: 9682388
[TBL] [Abstract][Full Text] [Related]
13. Defense mechanisms against primary influenza virus infection in mice. I. The roles of interferon and neutralizing antibodies and thymus dependence of interferon and antibody production.
Iwasaki T; Nozima T
J Immunol; 1977 Jan; 118(1):256-63. PubMed ID: 401512
[TBL] [Abstract][Full Text] [Related]
14. Migration of antigen-presenting B cells from peripheral to mucosal lymphoid tissues may induce intestinal antigen-specific IgA following parenteral immunization.
Coffin SE; Clark SL; Bos NA; Brubaker JO; Offit PA
J Immunol; 1999 Sep; 163(6):3064-70. PubMed ID: 10477570
[TBL] [Abstract][Full Text] [Related]
15. Cytokine mRNAs in the nasal-associated lymphoid tissue during influenza virus infection and nasal vaccination.
Matsuo K; Iwasaki T; Asanuma H; Yoshikawa T; Chen Z; Tsujimoto H; Kurata T; Tamura SS
Vaccine; 2000 Jan; 18(14):1344-50. PubMed ID: 10618531
[TBL] [Abstract][Full Text] [Related]
16. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract.
Renegar KB; Small PA; Boykins LG; Wright PF
J Immunol; 2004 Aug; 173(3):1978-86. PubMed ID: 15265932
[TBL] [Abstract][Full Text] [Related]
17. Induction of innate immunity by nasal influenza vaccine administered in combination with an adjuvant (cholera toxin).
Matsuo K; Yoshikawa T; Asanuma H; Iwasaki T; Hagiwara Y; Chen Z; Kadowaki SE; Tsujimoto H; Kurata T; Tamura SI
Vaccine; 2000 Jun; 18(24):2713-22. PubMed ID: 10781859
[TBL] [Abstract][Full Text] [Related]
18. Mucosal immunity of nasopharynx: an experimental study in TCR-transgenic (OVA23-3) mice.
Yamada T; Kataoka S; Ogasawara K; Ishimitsu R; Hashigucci K; Suzuki T; Kawauchi H
Rhinology; 2005 Sep; 43(3):190-8. PubMed ID: 16218512
[TBL] [Abstract][Full Text] [Related]
19. Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM.
Kris RM; Asofsky R; Evans CB; Small PA
J Immunol; 1985 Feb; 134(2):1230-5. PubMed ID: 2981265
[TBL] [Abstract][Full Text] [Related]
20. Comparative studies of local antibody and cellular immune responses to influenza infection and vaccination with live attenuated reassortant influenza vaccine (LAIV) utilizing a mouse nasal-associated lymphoid tissue (NALT) separation method.
Petukhova G; Naikhin A; Chirkova T; Donina S; Korenkov D; Rudenko L
Vaccine; 2009 Apr; 27(19):2580-7. PubMed ID: 19428864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
